A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia
Clinical trial NCT06107803 · COMPLETED
Trial details
- NCT number
- NCT06107803
- Sponsor
- Minerva Neurosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-13
- Primary completion
- 2024-01-12
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.